Sodium nitroprusside: low price and safe drug to control BP during thrombolysis in AIS

This study analyzes the use of sodium nitroprusside (SN) as an option to reduce blood pressure (BP) below 180/105 mmHg during the management of acute ischemic stroke (AIS) in patients submitted to intravenous thrombolysis.Method The sample was composed by 60 patients who had AIS and were submitted to intravenous rtPA, split in two groups: half in the control group (CG) with BP < 180/105 mmHg and half in SN group with BP > 180/105 mmHg. Outcome variables were any hemorrhagic transformation (HT); the presence of symptomatic HT, National Institute of Health Stroke Scale (NIHSS) after 24 hours of treatment; the independence on discharge and death until three months after stroke onset.Results There were no statistical differences between both groups to any of the outcome variables analyzed.Conclusion The SN might be safe for BP control during thrombolysis to AIS.

Bibliographic Details

Main Authors:	Koslyk,Jessyca L., Ducci,Renata D., Nóvak,Edison M., Zétola,Viviane F., Lange,Marcos C.
Format:	Digital revista
Language:	English
Published:	Academia Brasileira de Neurologia - ABNEURO 2015
Online Access:	http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015000900755
Tags:	Add Tag No Tags, Be the first to tag this record!